User profiles for Sjoerd T.T. Schetters
Sjoerd SchettersFWO Research Fellow, IRC-VIB Verified email at irc.vib-ugent.be Cited by 2601 |
The tumour glyco-code as a novel immune checkpoint for immunotherapy
E RodrÍguez, STT Schetters, Y van Kooyk - Nature Reviews …, 2018 - nature.com
Tumour growth is accompanied by tumour evasion of the immune system, a process that is
facilitated by immune checkpoint molecules such as programmed cell death protein 1 (PD1). …
facilitated by immune checkpoint molecules such as programmed cell death protein 1 (PD1). …
[HTML][HTML] Neuroinflammation: microglia and T cells get ready to tango
STT Schetters, D Gomez-Nicola… - Frontiers in …, 2018 - frontiersin.org
In recent years, many paradigms concerning central nervous system (CNS) immunology have
been challenged and shifted, including the discovery of CNS-draining lymphatic vessels, …
been challenged and shifted, including the discovery of CNS-draining lymphatic vessels, …
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology
The proliferation and activation of microglial cells is a hallmark of several neurodegenerative
conditions. This mechanism is regulated by the activation of the colony-stimulating factor 1 …
conditions. This mechanism is regulated by the activation of the colony-stimulating factor 1 …
[HTML][HTML] Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells
STT Schetters, WSP Jong, SK Horrevorts… - Acta biomaterialia, 2019 - Elsevier
Outer membrane vesicles (OMVs) are vesicular nano-particles produced by Gram-negative
bacteria that are recently being explored as vaccine vector. The fact that OMVs can be …
bacteria that are recently being explored as vaccine vector. The fact that OMVs can be …
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
…, SCM Bruijns, T van Ee, STT Schetters… - Nature …, 2021 - nature.com
Abstract Changes in glycosylation during tumour progression are a key hallmark of cancer.
One of the glycan moieties generally overexpressed in cancer are sialic acids, which can …
One of the glycan moieties generally overexpressed in cancer are sialic acids, which can …
[HTML][HTML] Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
STT Schetters, E Rodriguez, LJW Kruijssen… - … for Immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Original research: Monocyte-derived APCs are central to the response of PD1 checkpoint
blockade and provide a therapeutic target for combination therapy - PMC Back to Top Skip to …
blockade and provide a therapeutic target for combination therapy - PMC Back to Top Skip to …
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
…, LAM Cornelissen, STT Schetters… - Proceedings of the …, 2016 - National Acad Sciences
Sialic acids are negatively charged nine-carbon carboxylated monosaccharides that often
cap glycans on glycosylated proteins and lipids. Because of their strategic location at the cell …
cap glycans on glycosylated proteins and lipids. Because of their strategic location at the cell …
[PDF][PDF] Functional CD169 on macrophages mediates interaction with dendritic cells for CD8+ T cell cross-priming
…, L Hoogterp, K Olesek, MR Beijer, STT Schetters… - Cell reports, 2018 - cell.com
Splenic CD169 + macrophages are located in the marginal zone to efficiently capture blood-borne
pathogens. Here, we investigate the requirements for the induction of CD8 + T cell …
pathogens. Here, we investigate the requirements for the induction of CD8 + T cell …
Mouse DC-SIGN/CD209a as target for antigen delivery and adaptive immunity
STT Schetters, LJW Kruijssen… - Frontiers in …, 2018 - frontiersin.org
The efficacy of vaccination studies aimed at targeting antigens to human DC-SIGN (hDC-SIGN)
have been notoriously difficult to study in vivo, as eight dendritic cell-specific intercellular …
have been notoriously difficult to study in vivo, as eight dendritic cell-specific intercellular …
A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19
…, M Guilliams, STT Schetters… - Science Translational …, 2023 - science.org
Improvements in COVID-19 treatments, especially for the critically ill, require deeper
understanding of the mechanisms driving disease pathology. The complement system is not only a …
understanding of the mechanisms driving disease pathology. The complement system is not only a …